Clinical Trials in Czechia — Country Dashboard | 1,515 EU Studies

Filter these 1,515 trials by condition, phase, sponsor and more.

Open in Search →

1,515 Registered trials

553 Recruiting

864 Completed trials

467 Sponsors active

574 Research sites

Phase III

Phase II

Phase III: 883 Phase II/III: 77 Phase II: 349 Phase I/II: 33 Phase III/IV: 13 Phase IV: 38 Phase I: 16 Phase I (Other): 40 Phase I (FiH): 14 Other: 52

Oversight events in trials active here:

67 serious breaches 465 temporary halts 21 urgent safety measures 48 unexpected events 73 corrective measures across 203 trials

View oversight register →

Top conditions

Non-small cell lung cancer 21 Crohn's disease 18 Prostate cancer metastatic 15 Colitis ulcerative 15 Pulmonary arterial hypertension 15 Asthma 14 Ovarian cancer 13 Systemic lupus erythematosus 12 Obesity 12 Multiple sclerosis 12 Dermatitis atopic 12 Diffuse large B-cell lymphoma 11

Top sponsors

Novartis Pharma AG 86 Merck Sharp & Dohme LLC 66 Janssen - Cilag International 58 Sanofi-Aventis Recherche & Developpement 54 AstraZeneca AB 50 AbbVie Deutschland GmbH & Co. KG 45 Pfizer Inc. 42 F. Hoffmann-La Roche AG 36 Bristol-Myers Squibb Services Unlimited Company 29 Boehringer Ingelheim International GmbH 28 Amgen Inc. 27 Eli Lilly & Co. 26

Cities with most trials

All 184 cities →

All trials — page 64

1,515 total

A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons… Ended

2024-515393-27-00 Phase II Nonsquamous non-small cell lung cancer iTeos Belgium
A study to investigate the safety, tolerability, pharmacokinetics (PK), and preliminary anticancer activity of GSK4524101 alone or with nira… Ended

2024-520197-36-00 Phase I (FiH) Neoplasms Glaxosmithkline Research & Development Limited
A randomized, phase 3 multicenter clinical trial to confirm the clinical efficacy and evaluate the safety of linaprazan glurate compared to … Ended

2025-522750-39-00 Phase III Erosive esophagitis (EE) due to gastroesophageal reflux dise… Cinclus Pharma Holding AB (publ)

Showing 1,513–1,515 of 1,515 trials

← All countries